SEC reporting owner
| Reporting owner CIK | 0001736359 |
|---|---|
| Issuers | 2 |
| Qualifying disclosures | 26 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 3 |
| Last public filing | 2026-10-07 |
| Coverage | verified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-09-14 | 2026-09-10 | MRNA | S | 15,000 | Not reported |
| 2026-09-14 | 2026-09-10 | MRNA | S | 19,836 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 49,569 | Not reported |
| 2026-03-03 | 2026-03-01 | MRNA | A | 37,639 | Not reported |
| 2026-02-13 | 2026-02-11 | MRNA | A | 2,630 | Not reported |
| 2025-03-03 | 2025-03-01 | MRNA | A | 39,606 | Not reported |
| 2025-03-03 | 2025-03-01 | MRNA | A | 63,478 | Not reported |
| 2024-12-06 | 2024-12-05 | MRNA | A | 188,761 | Not reported |
| 2024-12-02 | 2024-11-29 | MRNA | S | 1,420 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.